Lipitor Still Raking It In; Niacin Eye Damage; Rising Heart Deaths
Recent developments of interest in cardiovascular medicine
Lipitor still brings in about $2 billion per year in sales despite generic atorvastatin's availability for years, in large part due to China and other emerging markets. (Axios)